Summary
Definition
História e exame físico
Principais fatores diagnósticos
- underlying lung disease
- chronic productive cough
- dyspnea
- weight loss
- fatigue
- fever
- lymphadenopathy
- immunocompromised
- hot tub use
Outros fatores diagnósticos
- age under 5 years
- middle-to-old age
- night sweats
- abdominal pain
- diarrhea
- rhonchi/crackles
- hepatomegaly
- splenomegaly
- thin body habitus
- pectus excavatum
- scoliosis
- systolic click and murmur
Fatores de risco
- underlying lung diseases
- smoking
- excessive alcohol use
- increasing age
- hot tub use
- HIV/AIDS
- severe immunosuppression
- genetic cytokine defects
Investigações diagnósticas
Primeiras investigações a serem solicitadas
- CBC with differential
- LFT
- chest x-ray
- sputum culture
- blood culture
Investigações a serem consideradas
- high-resolution CT (HRCT) scanning
- bone marrow aspirate for culture
- bronchoscopy/bronchial lavage
- lung biopsy
- lymph node biopsy
Novos exames
- polymerase chain reaction
Algoritmo de tratamento
pulmonary MAC
disseminated MAC
MAC lymphadenitis
MAC hypersensitivity pneumonitis
Colaboradores
Autores
Zelalem Temesgen, MD, FIDSA

Professor of Medicine
Director, Mayo Clinic Center for Tuberculosis
Director, HIV Program
Consultant, Division of Infectious Diseases
Mayo Clinic
Rochester
MN
Declarações
ZT declares that he has no competing interests.
Agradecimentos
Dr Temesgen would like to gratefully acknowledge Dr Dereje S. Ayo, a previous contributor to this topic.
Declarações
DSA declares that he has no competing interests.
Revisores
Jonathan P. Parsons, MD
Assistant Professor
Division of Pulmonary, Allergy, Critical Care and Sleep Medicine
Ohio State University Medical Center
Columbus
OH
Declarações
JPP declares that he has no competing interests.
Sandro Vento, MD
Director
Infectious Diseases Unit
Annunziata Hospital
Cosenza
Italy
Declarações
SV declares that he has no competing interests.
Referências
Principais artigos
National Institutes of Health, Centers for Disease Control and Prevention, HIV Medicine Association, and Infectious Diseases Society of America. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: Disseminated mycobacterium avium complex disease. 2024 [internet publication].Texto completo
Griffith DE, Aksamit T, Brown-Elliott BA, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007 Feb 15;175(4):367-416.Texto completo Resumo
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Clin Infect Dis. 2020 Aug 14;71(4):e1-36.Texto completo Resumo
Haworth CS, Banks J, Capstick T, et al. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). Thorax. 2017 Nov;72(suppl 2):ii1-64.Texto completo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.
Diagnósticos diferenciais
- Pulmonary tuberculosis
- Other nontuberculous mycobacteria (NTM)
- HIV-related lymphoma
Mais Diagnósticos diferenciaisDiretrizes
- Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV
- Guidelines for the prevention and treatment of opportunistic infections in children with and exposed to HIV
Mais DiretrizesFolhetos informativos para os pacientes
Quitting smoking
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal